StockData
SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Septerna, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$36.38+0.03 (+0.08%)

Close on Oct 19, 2026

Market cap
$1.64B
P/E (TTM)
–
Dividend yield
–

Septerna, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Septerna does not break out revenue by segment, region or product in the tagged data of its filings for this period type.